Patience C. Motshosi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patience C. Motshosi has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Gorata Mpebe
Botswana Harvard Health Partnership, Private Bag BO320, Gaborone, Botswana
4 shared publications - Mosimanegape Jongman
Botswana Harvard Health Partnership, Gaborone BO 320, Botswana
4 shared publications - Sikhulile Moyo
Botswana Harvard Health Partnership, Gaborone, Botswana, Botswana
4 shared publications - Simani Gaseitsiwe
Botswana Harvard Health Partnership, Private Bag BO320, Gaborone, Botswana
4 shared publications - Tsholofelo Ratsoma
Botswana Harvard Health Partnership, Private Bag BO320, Gaborone, Botswana
4 shared publications - Wonderful Tatenda Choga
Botswana Harvard Health Partnership, Gaborone, Botswana, Botswana
4 shared publications
Latest Publications
- Open Access
Surveillance of Pathogenic Bacteria and Antimicrobial Resistance Determinants in Surface Water and Human Plasma Using Metagenomic Sequencing in the Ngamiland and Okavango Delta Regions
(1) Background: Antimicrobial resistance poses a critical global public health threat, with surface water acting as a potential reservoir for pathogenic, zoonotic, and AMR determinants and transmission pathways between humans and animals. We aimed to detect bacterial DNA of clinically relevant taxa and putative AMR determinants in surface water and human beings to support the expansion of One Health environmental surveillance in the Ngamiland and Okavango Delta regions. (2) Methods: We performed a cross-sectional environmental surveillance study using metagenomic sequencing. We collected 28 surface-water samples from Thamalakane River and Moremi Game Reserve sampling sites: 12 samples from Mall of Maun, Island Safari Lodge, and Police Bridge sites along the Thamalakane River, and 16 samples from Xakanaxa, Maxwexwana, Paradise, and Jessie’s Pools sites in Moremi Game Reserve. Additionally, 72 human plasma samples from Letsholathebe II Memorial District Hospital in Maun were also sequenced. Taxonomic classification was performed using Kraken2, and predictive AMR gene identification was performed using the CZ ID AMR module. Beta-diversity was assessed using Principal Coordinates Analysis and PERMANOVA for significant differences in bacterial and AMR gene composition. A p-value of less than 0.05 was considered to be statistically significant. (3) Results: Thamalakane River was dominated by Acinetobacter schindleri (~27%), Acinetobacter lwoffii (~67%), and the toxic cyanobacterium Microcystis aeruginosa (~99%). Moremi Game Reserve sites showed more varied dominant bacterial species, including Stenotrophomonas maltophilia at two sites (~26% and ~29%), Microcystis aeruginosa (~60%), P. aeruginosa (~20%), P. putida (~13%), and A. baumannii (~10%). Beta diversity analysis suggested differences in bacterial community composition between locations (PERMANOVA: R2 = 0.261, p = 0.001). Only 5 out of 28 bacterial species identified were shared between surface water and human plasma samples. No putative AMR genes were detected in human samples. However, only intrinsic efflux pump genes (mex-, sme-, ade-families, etc.) dominated surface water. Beta diversity analysis suggested differences in bacterial community composition between locations. (4) Conclusions: Detection of bacterial DNA of clinically relevant bacterial taxa in both surface water and human samples and putative AMR determinants in surface water samples only highlights the need for expanded One Health environmental surveillance. Even though no putative AMR genes were detected in human plasma, monitoring the emergence and transmission of pathogens and resistance-associated genes between One Health interfaces remains a significant research area that requires further investigation.
Open AccessSurveillance of Pathogenic Bacteria and Antimicrobial Resistance Determinants in Surface Water and Human Plasma Using Metagenomic Sequencing in the Ngamiland and Okavango Delta Regions
(1) Background: Antimicrobial resistance poses a critical global public health threat, with surface water acting as a potential reservoir for pathogenic, zoonotic, and AMR determinants and transmission pathways between humans and animals. We aimed to detect bacterial DNA of clinically relevant taxa and putative AMR determinants in surface water and human beings to support the expansion of One Health environmental surveillance in the Ngamiland and Okavango Delta regions. (2) Methods: We performed a cross-sectional environmental surveillance study using metagenomic sequencing. We collected 28 surface-water samples from Thamalakane River and Moremi Game Reserve sampling sites: 12 samples from Mall of Maun, Island Safari Lodge, and Police Bridge sites along the Thamalakane River, and 16 samples from Xakanaxa, Maxwexwana, Paradise, and Jessie’s Pools sites in Moremi Game Reserve. Additionally, 72 human plasma samples from Letsholathebe II Memorial District Hospital in Maun were also sequenced. Taxonomic classification was performed using Kraken2, and predictive AMR gene identification was performed using the CZ ID AMR module. Beta-diversity was assessed using Principal Coordinates Analysis and PERMANOVA for significant differences in bacterial and AMR gene composition. A p-value of less than 0.05 was considered to be statistically significant. (3) Results: Thamalakane River was dominated by Acinetobacter schindleri (~27%), Acinetobacter lwoffii (~67%), and the toxic cyanobacterium Microcystis aeruginosa (~99%). Moremi Game Reserve sites showed more varied dominant bacterial species, including Stenotrophomonas maltophilia at two sites (~26% and ~29%), Microcystis aeruginosa (~60%), P. aeruginosa (~20%), P. putida (~13%), and A. baumannii (~10%). Beta diversity analysis suggested differences in bacterial community composition between locations (PERMANOVA: R2 = 0.261, p = 0.001). Only 5 out of 28 bacterial species identified were shared between surface water and human plasma samples. No putative AMR genes were detected in human samples. However, only intrinsic efflux pump genes (mex-, sme-, ade-families, etc.) dominated surface water. Beta diversity analysis suggested differences in bacterial community composition between locations. (4) Conclusions: Detection of bacterial DNA of clinically relevant bacterial taxa in both surface water and human samples and putative AMR determinants in surface water samples only highlights the need for expanded One Health environmental surveillance. Even though no putative AMR genes were detected in human plasma, monitoring the emergence and transmission of pathogens and resistance-associated genes between One Health interfaces remains a significant research area that requires further investigation.
- Open Access
Deep Sequencing of Hepatitis B Virus Reveals Clinically Relevant Low-Frequency Variants Among People Living with HIV in Botswana
(1) Background: The Hepatitis B virus (HBV) is characterized by extensive genetic diversity, including low-frequency variants that contribute to disease progression. We aimed to characterize low-frequency variants and evaluate their potential clinical impact. (2) Methods: We utilized 104 HBV near-full-length sequences generated using next-generation sequencing (NGS) from people living with HIV (PLHIV). We used an in-house bioinformatics suite (HBVgenomeR v5.9.7) to filter for low-frequency variants (5–50%), which were compared to escape and drug resistance mutations (DRMs) and hepatocellular carcinoma (HCC)-associated mutations reported at the consensus level. Unclassified variants were characterized by HBV open reading frames (ORFs) to determine mutation frequency per genomic region. (3) Results: A total of six escape mutations were detected in 8/104 (7.7%) sequences, with surfaceN131T being the most prevalent (5/8). We also observed six DRMs in 30/104 (28.8%), with rtV173L being the most prevalent (21/30). Truncation mutations were also observed with rtA181T/sW172* and rtM204I/sW196L being the most prevalent. A total of 8/104 (7.7%) sequences had four variants associated with HCC. The xP46S was the highest observed HCC-associated mutation at 5/8. We report 1152 unique uncharacterized variants across all ORFs, and these were found in 94/104 (90.4%) sequences. The RNaseH domain had the highest burden (330/1152, 28.6%). (4) Conclusions: Deep sequencing results identified clinically significant mutations, including those below the 20% detection limit of traditional sequencing, that would go unreported. This highlights the possible underreporting of mutational burden in people living with HBV/HIV, indicating the importance of deep sequencing to aid in HBV/HIV understanding and management.
Open AccessDeep Sequencing of Hepatitis B Virus Reveals Clinically Relevant Low-Frequency Variants Among People Living with HIV in Botswana
(1) Background: The Hepatitis B virus (HBV) is characterized by extensive genetic diversity, including low-frequency variants that contribute to disease progression. We aimed to characterize low-frequency variants and evaluate their potential clinical impact. (2) Methods: We utilized 104 HBV near-full-length sequences generated using next-generation sequencing (NGS) from people living with HIV (PLHIV). We used an in-house bioinformatics suite (HBVgenomeR v5.9.7) to filter for low-frequency variants (5–50%), which were compared to escape and drug resistance mutations (DRMs) and hepatocellular carcinoma (HCC)-associated mutations reported at the consensus level. Unclassified variants were characterized by HBV open reading frames (ORFs) to determine mutation frequency per genomic region. (3) Results: A total of six escape mutations were detected in 8/104 (7.7%) sequences, with surfaceN131T being the most prevalent (5/8). We also observed six DRMs in 30/104 (28.8%), with rtV173L being the most prevalent (21/30). Truncation mutations were also observed with rtA181T/sW172* and rtM204I/sW196L being the most prevalent. A total of 8/104 (7.7%) sequences had four variants associated with HCC. The xP46S was the highest observed HCC-associated mutation at 5/8. We report 1152 unique uncharacterized variants across all ORFs, and these were found in 94/104 (90.4%) sequences. The RNaseH domain had the highest burden (330/1152, 28.6%). (4) Conclusions: Deep sequencing results identified clinically significant mutations, including those below the 20% detection limit of traditional sequencing, that would go unreported. This highlights the possible underreporting of mutational burden in people living with HBV/HIV, indicating the importance of deep sequencing to aid in HBV/HIV understanding and management.
- Open Access
Hepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIV
Hepatitis delta virus (HDV) co-infections more often result in severe hepatitis compared to hepatitis B virus (HBV) infections alone. Despite a high HDV prevalence (7.1%), information regarding circulating HDV clades is very limited in Botswana. We extracted total nucleic acid from confirmed HDV-positive samples and quantified their viral load. We then sequenced the large hepatitis delta antigen (L-HDAg) using Oxford Nanopore Technology (ONT). Genotyping was performed using the HDV Database, and HDV mutation profiling was performed on AliView. All participants with HBV genotypic information belonged to sub-genotype A1, and 80% (4/5) of them had a higher HDV viral load and a lower HBV viral load. We sequenced 75% (9/12) of the HDV-positive samples, which belonged to HDV clade 8. A total of 54 mutations were discovered, with the most prevalent being Q148R (16%), D149P (16%) and G151D (16%). Known mutations such as S117A, K131R, R139K and G151D were detected, while the other mutations were novel. Our results reveal that HDV clade 8 is the predominant clade in Botswana. The significance of all mutations remains unclear. Future studies with a larger sample size to detect other HDV clades that might be circulating in Botswana and functionally characterize the detected mutations are warranted.
Open AccessHepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIV
Hepatitis delta virus (HDV) co-infections more often result in severe hepatitis compared to hepatitis B virus (HBV) infections alone. Despite a high HDV prevalence (7.1%), information regarding circulating HDV clades is very limited in Botswana. We extracted total nucleic acid from confirmed HDV-positive samples and quantified their viral load. We then sequenced the large hepatitis delta antigen (L-HDAg) using Oxford Nanopore Technology (ONT). Genotyping was performed using the HDV Database, and HDV mutation profiling was performed on AliView. All participants with HBV genotypic information belonged to sub-genotype A1, and 80% (4/5) of them had a higher HDV viral load and a lower HBV viral load. We sequenced 75% (9/12) of the HDV-positive samples, which belonged to HDV clade 8. A total of 54 mutations were discovered, with the most prevalent being Q148R (16%), D149P (16%) and G151D (16%). Known mutations such as S117A, K131R, R139K and G151D were detected, while the other mutations were novel. Our results reveal that HDV clade 8 is the predominant clade in Botswana. The significance of all mutations remains unclear. Future studies with a larger sample size to detect other HDV clades that might be circulating in Botswana and functionally characterize the detected mutations are warranted.
- Open Access
Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations
The interaction of multiple viruses in one host is thought to enhance the development of mutations. However, the impact of hepatitis D virus (HDV) positivity on the development of unique hepatitis B virus (HBV) mutations among people living with human immunodeficiency virus (HIV) (PLWH) remains poorly understood in African countries, including Botswana. We used HBV sequences generated from the Botswana Combination Prevention Project (BCPP), which is the largest pair-matched cluster-randomized HIV trial in Botswana. Only participants with available HBV sequences (n = 55) were included in our study ([HIV/HBV-positive (n = 50) and HIV/HBV/HDV-positive (n = 5)]. Geno2pheno was used to determine HBV genotypes, and HBV surface region sequences (all subgenotype A1) were aligned in AliView for mutational analysis, while the impact of mutations was assessed using Phyre2. Our results identified 182 common mutations between the two groups. In the HIV/HBV/HDV cohort, only three mutations (L95W, W156Q, C221Y) were classified as deleterious, with only L95W being the most frequent. In the HIV/HBV cohort, four mutations (W199R, C221A, C221S, W223G) were also classified as deleterious. Our results demonstrate the presence of unique HBV mutations among the HIV/HBV/HDV-positive cohort. Functional characterization of these mutations is recommended to determine their effect on HDV.
Open AccessImpact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations
The interaction of multiple viruses in one host is thought to enhance the development of mutations. However, the impact of hepatitis D virus (HDV) positivity on the development of unique hepatitis B virus (HBV) mutations among people living with human immunodeficiency virus (HIV) (PLWH) remains poorly understood in African countries, including Botswana. We used HBV sequences generated from the Botswana Combination Prevention Project (BCPP), which is the largest pair-matched cluster-randomized HIV trial in Botswana. Only participants with available HBV sequences (n = 55) were included in our study ([HIV/HBV-positive (n = 50) and HIV/HBV/HDV-positive (n = 5)]. Geno2pheno was used to determine HBV genotypes, and HBV surface region sequences (all subgenotype A1) were aligned in AliView for mutational analysis, while the impact of mutations was assessed using Phyre2. Our results identified 182 common mutations between the two groups. In the HIV/HBV/HDV cohort, only three mutations (L95W, W156Q, C221Y) were classified as deleterious, with only L95W being the most frequent. In the HIV/HBV cohort, four mutations (W199R, C221A, C221S, W223G) were also classified as deleterious. Our results demonstrate the presence of unique HBV mutations among the HIV/HBV/HDV-positive cohort. Functional characterization of these mutations is recommended to determine their effect on HDV.